United States Digital Therapeutics Market Report - Shares, Size, Statistics, Revenue, Professional Survey on Proteus Digital Health, Inc., Livongo Health and Omada Health Inc. for (2018 to 2025)

The global digital therapeutics market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period. Over the next five years, the growth of the market is likely to be centered on the U.S.

Report "Digital Therapeutics Market", Global digital therapeutics market expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.
#Access PDF Brochure on “Digital Therapeutics Market” Report Now at
https://www.reportsnreports.com/contacts/requestsample.aspx?name=610187 .

In digital therapeutics market Government initiatives to support development & adoption of digital therapeutics solutions also provide an impetus for growth of market. For instance, U.S. Congress authorized Centers for Disease Control and Prevention (CDC) to create Diabetes Prevention Recognition Program (DPRP) & recognize programs that meet evidence-based standards provided by DPRP.

In addition, company profiles comprise basic views on key players in digital therapeutics market and their product portfolios, developments, and strategies. Above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products & technologies, & levels of output in order to remain successful.

#Table of Content

1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Digital Therapeutics Market, By Sales Channel
8 Digital Therapeutics Market, By Type of Application
9 Digital Therapeutics Market, By Region
10 Competitive Landscape
11 Company Profiles
12 Appendix

#Get Discount Digital Therapeutics Market with Top Trends and Global Forecast at https://www.reportsnreports.com/contacts/discount.aspx?name=610187 .

North America dominates digital therapeutics market, with U.S. accounting for major share & highest CAGR. This can be attributed to growing incidence of chronic diseases, government initiatives to support technological advancements in digital therapeutics, gradually improving reimbursement structure for digital therapeutics solutions, & a growing influx of new startup companies in market as a result of increasing investments in digital therapeutics field.

Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments)
1. Proteus Digital Health, Inc.
2. Omada Health, Inc.
3. Welldoc, Inc.
4. Livongo Health
5. Noom Inc.
6. Ginger.Io, Inc.
7. Propeller Health
8. 2morrow Inc.
9. Canary Health Inc.
10. Mango Health Inc.

#More Details on “Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021” report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=610187 .

Report will enrich both established firms as well as new entrants/smaller firms to gauge pulse of market, which in turn will help firms garner a greater market share. Firms purchasing report can use any one or a combination of below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, & competitive assessment) for strengthening their market shares.

Recent Developments
• In Febuary 2016, Omada Health, Inc. launched a new version of its diabetes prevention program, Prevent. The new product includes additional features designed to meet the needs of underserved populations. This launch enabled the company to improve its product offerings and expand its customer base.
• In March 2016, WellDoc, Inc. entered into a strategic collaboration with LifeScan, Inc. (U.S .), a Johnson & Johnson (U.S.) company, to provide digital therapeutic solutions for patients with type 2 diabetes. As per this collaboration, WellDoc’s product Bluestar will be integrated with LifeScan’s products OneTouchVerio Fle Bluetooth Smart blood glucose monitoring system and OneTouch Revealmobile app. This collaboration enabled WellDoc to access Johnson and Johnson’s large patient base.
• In May 2016, Humana Inc. (U.S.), a leading health and well -being company in the U.S., made a strategic equity investment in Livongo Health. This investment enables the company to support its growth and accelerate the launch of new products and services in the market
• In April 2016, Proteus Digital Health, Inc. received a Series H financing worth USD 50 million. This enabled the company to expand its Digital Medicines platform.

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.